Navigation Links
Palatin Technologies, Inc. March 31, 2011 Quarter Results; Teleconference and Webcast to be Held on May 16, 2011
Date:5/12/2011

CRANBURY, N.J., May 12, 2011 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) will host a conference call and webcast on May 16, 2011 at 11:00 a.m. Eastern Time to discuss its quarter ended March 31, 2011 financial results and its programs, focusing on the upcoming start of its Phase 2 clinical trial with bremelanotide for women with female sexual dysfunction.  Schedule for the Financial Results Press Release, Conference Call / WebcastQ3 Fiscal Year 2011 Conference Call-Live

5/16/2011 at 11:00 a.m. ETDomestic Dial-In Number

1-866-316-1363International Dial-In Number

1-913-312-0861Pass code

2950108Q3 Fiscal Year 2011 Conference Call-Replay

5/16-5/23/2011Domestic Dial-In Number

1-888-203-1112International Dial-In Number

1-719-457-0820Pass code

2950108Webcast Live and Replay Access

http://www.palatin.comThe webcast and replay can be accessed by logging on to the “Investor/Media Center-Webcasts” section of Palatin’s website at http://www.palatin.comAbout Palatin Technologies, Inc.Palatin Technologies, Inc. is a biopharmaceutical company dedicated to the development of peptide, peptide mimetic and small molecule agonists with a focus on melanocortin and natriuretic peptide receptor systems. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential.  For additional information regarding Palatin, please visit Palatin Technologies' website at www.palatin.com.


'/>"/>
SOURCE Palatin Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. FDA Clears Palatin Technologies IND Filing to Commence Clinical Studies for Asthma
2. Palatin Technologies, Inc. Closes $23 Million Public Offering
3. Palatin Technologies Listing Compliance Plan Accepted by NYSE Amex
4. Palatin Technologies Receives Non-Compliance Letter from NYSE Amex
5. Palatin Technologies to Present at 9th Annual BIO Investor Forum
6. Palatin Technologies to Present at Rodman & Renshaw Annual Global Investment Conference
7. Palatin Technologies, Inc. Announces Positive Safety Results in Subcutaneous Bremelanotide Trial in Men
8. Palatin Technologies, Inc. Receives $2.5 Million from AstraZeneca
9. Palatin Technologies, Inc. To Raise $2.6 Million Dollars in Registered Direct Offering
10. Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men
11. Palatin Technologies to Present at 8th Annual BIO Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global ... and Gynecology markets with innovative and proprietary products, will ... 31, 2017 after the market close on Tuesday, May ... a conference call and webcast to discuss its financial ... at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). ...
(Date:4/18/2017)...  Astute Medical, Inc., developer of biomarkers for better ... at the 2017 National Kidney Foundation (NKF) Spring ... April 22. Physicians will present data on two biomarkers, ... for acute kidney injury (AKI) during the management of ... Elevated levels of TIMP-2 and IGFBP-7 have been ...
Breaking Medicine Technology:
(Date:4/24/2017)... ... April 24, 2017 , ... MAP Health Management ... levels in people with addiction who are served by MAP’s patient engagement ecosystem. ... device that monitors heart and breath rates to identify anxiety levels and can ...
(Date:4/24/2017)... ... ... Come to PAINWeekEnd (PWE) Tampa on May 20 and 21, at the ... 2-day program. , An attendee at a recent PAINWeekEnd said, "Very helpful, wish ... course entitled Ain't Misbehavin': Decreasing and Managing Pain Patient Aberrant Behavior, presented by Dr. ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Reflections of God’s Work”: an ... of God’s Work” is the creation of published author, Jerri Broglin, a survivor of ... , “I believe this a great eye-opener for those searching for answers, as we ...
(Date:4/24/2017)... ... ... Life of Purpose Treatment is proud to present “An Evening for Collegiate Recovery ... on May 10th at the University Auditorium. , This benefit concert, featuring Dr. Cheryl ... Collegiate Recovery Community (UFCRC). The concert will kick off the 5th Annual Southeastern CRC ...
(Date:4/23/2017)... ... April 23, 2017 , ... "An event Horizon is a place where the ... my Art and Music. These are created as Metaphysical Transformations where music, which is ... culminate to the ultimate singularity.", -- Karen Salicath Jamali , Karen will also preview ...
Breaking Medicine News(10 mins):